| TBIO Snapshot | |
|---|---|
| Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutic company, develops drugs to treat diseases caused by protein or gene dysfunction. The company is headquartered in Lexington, Massachusetts. | |
| VALUATION DATA | |
| Market Capitalization | $9,934,100 | Price to Sales | 6.00 |
| Earnings per Share | $-1.6400 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.3214 |
| 52 Week High | $0.449 |
| 52 Week Low | $51.86 |
| 50-Day Moving Average | $2.067 |
| 200-Day Moving Average | $-1.404 |
| All data are from Alpha Vantage as of today. For more infomation on TBIO see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search